GLP-1 weight regain after stopping: what the data says

What did @manifestwanna actually say?

Honestly? The transcript here is not usable. The auto-generated captions from this video are garbled to the point of being meaningless, producing lines like "I wish you a fun, fun, fun" that have no coherent medical or behavioral content. What we can work with is the caption the creator wrote themselves, which is far more revealing than any transcript.

In that caption, @manifestwanna describes a cycle that will be familiar to a lot of people on GLP-1 medications: significant weight loss followed by significant regain, and the psychological toll that cycle takes. They explicitly tie their sense of self-worth to their body, writing about wanting to "be worthy now." That framing, weight loss as a prerequisite for worthiness, is the thing worth examining here.

Does the science back up the regain-and-shame cycle they describe?

The regain part? Completely backed by data. The shame response to it? Understandable, but not medically warranted, and potentially harmful.

The STEP 1 extension trial (Wilding et al., 2022, New England Journal of Medicine) followed semaglutide users after they stopped the medication and found participants regained roughly two-thirds of their lost weight within a year. This is not a personal failure. It reflects what researchers now understand about obesity as a chronic, relapsing condition with a strong physiological basis. Adipose tissue and gut hormones actively fight back against weight loss in ways that have nothing to do with willpower or character.

What the creator is describing, losing weight and then regaining, is pharmacologically expected when GLP-1 therapy is discontinued or when dosing is inconsistent. That does not make someone "unworthy."

What did they get wrong, or right?

The creator did not make any direct medical claims in their caption or in the (incoherent) transcript. So there is nothing factually wrong to correct in terms of drug information or dosing advice.

What deserves a closer look is the framing around worthiness. The creator writes about wanting to "be worthy now," implying they do not currently feel that way. Research on weight stigma, including a 2018 review by Puhl and Himmelstein in Obesity Reviews, consistently shows that internalized weight stigma is independently associated with worse mental health outcomes, binge eating behaviors, and, critically, reduced engagement with evidence-based treatment. In other words, feeling unworthy because of weight regain can actually make the regain worse. That is not a moralizing observation. It is a documented clinical pattern.

The creator is asking for prayers and affirmations, which is their choice. But it is worth noting that structured behavioral support alongside GLP-1 therapy, not shame, is what the clinical literature supports as effective.

What should you actually know about GLP-1 use and weight regain?

A few things matter here that most TikTok content misses entirely.

• GLP-1 receptor agonists like semaglutide and tirzepatide work on appetite signaling in ways that require ongoing use to maintain effect. Stopping the medication typically means the physiological drivers of weight return. This is not a character flaw.
• The SURMOUNT-1 trial (Jastreboff et al., 2022, NEJM) showed tirzepatide produced up to 22.5% body weight reduction, but those results depend on continued treatment and behavioral support.
• Internalized weight stigma, the kind the creator is describing, has measurable negative health effects independent of body weight itself. Puhl and Brownell's work published across multiple journals from 2003 onward established this repeatedly.
• If someone has regained weight after GLP-1 therapy, the clinical conversation should be about why, such as discontinuation, dose, adherence, stress, sleep, medication interactions, not about moral failure.

Is there anything actually useful in this video for someone considering GLP-1 treatment?

Not medically, because the transcript is unusable. But the caption surfaces something real. A lot of people pursuing GLP-1 treatment carry significant psychological weight alongside the physical kind, and that matters clinically. Providers who only address the pharmacology and ignore the internalized stigma piece are likely leaving outcomes on the table.

If you recognize yourself in what this creator describes, the regain cycle, the self-worth tied to scale numbers, the hope and disappointment, those are things worth bringing to a clinical conversation, not just an affirmations comment section.